Viewing Study NCT00280969

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-29 @ 1:42 PM
Study NCT ID: NCT00280969
Status: COMPLETED
Last Update Posted: 2015-03-30
First Post: 2006-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Sponsor: International Medical Center of Japan
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV infection View
None treatment View
None efavirenz View
None atazanavir View
None ritonavir View